These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10194551)

  • 1. Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats.
    Higuchi T; Yang DJ; Ilgan S; Tansey LW; Zareneyrizi F; Inoue T; Endo K; Kim EE; Podoloff DA
    Anticancer Drugs; 1999 Jan; 10(1):89-95. PubMed ID: 10194551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
    Li C; Yu DF; Inoue T; Yang DJ; Tansey W; Liu CW; Milas L; Hunter NR; Kim EE; Wallace S
    J Nucl Med; 1997 Jul; 38(7):1042-7. PubMed ID: 9225788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging tumor folate receptors using 111In-DTPA-methotrexate.
    Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 1998 Jun; 13(3):177-84. PubMed ID: 10850353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
    Delpassand ES; Yang DJ; Wallace S; Cherif A; Quadri SM; Price J; Joubert A; Inoue T; Podoloff DA
    J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
    Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP
    J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
    Müller C; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
    Reubi JC; Waser B; Schaer JC; Laederach U; Erion J; Srinivasan A; Schmidt MA; Bugaj JE
    Eur J Nucl Med; 1998 May; 25(5):481-90. PubMed ID: 9575243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
    Camera L; Kinuya S; Garmestani K; Brechbiel MW; Wu C; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
    Eur J Nucl Med; 1994 Jul; 21(7):640-6. PubMed ID: 7957350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new DTPA-derivative chelator: comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts.
    Camera L; Kinuya S; Garmestani K; Pai LH; Brechbiel MW; Gansow OA; Paik CH; Pastan I; Carrasquillo JA
    Nucl Med Biol; 1993 Nov; 20(8):955-62. PubMed ID: 8298575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
    Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
    Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of 111In-labeled hematoporphyrin derivative in breast tumor-bearing animals.
    Wong DW; Mandal A; Brown J; Reese IC; Siegler R; Hyman S
    Int J Rad Appl Instrum B; 1989; 16(3):269-81. PubMed ID: 2523878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
    Andersson P; Forssell-Aronsson E; Johanson V; Wängberg B; Nilsson O; Fjälling M; Ahlman H
    J Nucl Med; 1996 Dec; 37(12):2002-6. PubMed ID: 8970523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
    Duncan JR; Stephenson MT; Wu HP; Anderson CJ
    Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
    Turner A; King DJ; Farnsworth AP; Rhind SK; Pedley RB; Boden J; Boden R; Millican TA; Millar K; Boyce B
    Br J Cancer; 1994 Jul; 70(1):35-41. PubMed ID: 8018538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
    Inoue T; Li C; Yang DJ; Higuchi T; Oriuchi N; Yu D; Milas L; Hunter N; Wallace S; Kim EE; Podoloff DA
    Ann Nucl Med; 1999 Jun; 13(3):169-74. PubMed ID: 10435377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.